Literature DB >> 25348195

A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression.

Brian W Simons1, Nicholas M Durham, Tullia C Bruno, Joseph F Grosso, Anthony J Schaeffer, Ashley E Ross, Paula J Hurley, David M Berman, Charles G Drake, Praveen Thumbikat, Edward M Schaeffer.   

Abstract

Inflammation is associated with several diseases of the prostate including benign enlargement and cancer, but a causal relationship has not been established. Our objective was to characterize the prostate inflammatory microenvironment after infection with a human prostate-derived bacterial strain and to determine the effect of inflammation on prostate cancer progression. To this end, we mimicked typical human prostate infection with retrograde urethral instillation of CP1, a human prostatic isolate of Escherichia coli. CP1 bacteria were tropic for the accessory sex glands and induced acute inflammation in the prostate and seminal vesicles, with chronic inflammation lasting at least 1 year. Compared to controls, infection induced both acute and chronic inflammation with epithelial hyperplasia, stromal hyperplasia, and inflammatory cell infiltrates. In areas of inflammation, epithelial proliferation and hyperplasia often persist, despite decreased expression of androgen receptor (AR). Inflammatory cells in the prostates of CP1-infected mice were characterized at 8 weeks post-infection by flow cytometry, which showed an increase in macrophages and lymphocytes, particularly Th17 cells. Inflammation was additionally assessed in the context of carcinogenesis. Multiplex cytokine profiles of inflamed prostates showed that distinct inflammatory cytokines were expressed during prostate inflammation and cancer, with a subset of cytokines synergistically increased during concurrent inflammation and cancer. Furthermore, CP1 infection in the Hi-Myc mouse model of prostate cancer accelerated the development of invasive prostate adenocarcinoma, with 70% more mice developing cancer by 4.5 months of age. This study provides direct evidence that prostate inflammation accelerates prostate cancer progression and gives insight into the microenvironment changes induced by inflammation that may accelerate tumour initiation or progression.
Copyright © 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  Escherichia coli; inflammation; mouse; prostate; prostatitis

Mesh:

Substances:

Year:  2015        PMID: 25348195      PMCID: PMC4352321          DOI: 10.1002/path.4472

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  47 in total

Review 1.  Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling?

Authors:  Ivan V Litvinov; Angelo M De Marzo; John T Isaacs
Journal:  J Clin Endocrinol Metab       Date:  2003-07       Impact factor: 5.958

2.  Bacterial dna sequences in prostate tissue from patients with prostate cancer and chronic prostatitis.

Authors:  J N Krieger; D E Riley; R L Vesella; D C Miner; S O Ross; P H Lange
Journal:  J Urol       Date:  2000-10       Impact factor: 7.450

3.  Evaluation of the bacterial flora of the prostate using a 16S rRNA gene based polymerase chain reaction.

Authors:  W W Hochreiter; J L Duncan; A J Schaeffer
Journal:  J Urol       Date:  2000-01       Impact factor: 7.450

4.  MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells.

Authors:  Tsuyoshi Iwata; Denise Schultz; Jessica Hicks; Gretchen K Hubbard; Laura N Mutton; Tamara L Lotan; Carlise Bethel; Matthew T Lotz; Srinivasan Yegnasubramanian; William G Nelson; Chi V Dang; MengMeng Xu; Uzoma Anele; Cheryl M Koh; Charles J Bieberich; Angelo M De Marzo
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

5.  Leukocytic promotion of prostate cellular proliferation.

Authors:  Kristy L McDowell; Lesa A Begley; Nirit Mor-Vaknin; David M Markovitz; Jill A Macoska
Journal:  Prostate       Date:  2010-03-01       Impact factor: 4.104

Review 6.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

Review 7.  Epidemiology of inflammation and prostate cancer.

Authors:  Elizabeth A Platz; Angelo M De Marzo
Journal:  J Urol       Date:  2004-02       Impact factor: 7.450

Review 8.  Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee.

Authors:  Scott B Shappell; George V Thomas; Richard L Roberts; Ron Herbert; Michael M Ittmann; Mark A Rubin; Peter A Humphrey; John P Sundberg; Nora Rozengurt; Roberto Barrios; Jerrold M Ward; Robert D Cardiff
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

9.  Myc-driven murine prostate cancer shares molecular features with human prostate tumors.

Authors:  Katharine Ellwood-Yen; Thomas G Graeber; John Wongvipat; M Luisa Iruela-Arispe; JianFeng Zhang; Robert Matusik; George V Thomas; Charles L Sawyers
Journal:  Cancer Cell       Date:  2003-09       Impact factor: 31.743

10.  Prostatitis, sexually transmitted diseases, and prostate cancer: the California Men's Health Study.

Authors:  Iona Cheng; John S Witte; Steven J Jacobsen; Reina Haque; Virginia P Quinn; Charles P Quesenberry; Bette J Caan; Stephen K Van Den Eeden
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

View more
  29 in total

Review 1.  The inflammatory microenvironment and microbiome in prostate cancer development.

Authors:  Karen S Sfanos; Srinivasan Yegnasubramanian; William G Nelson; Angelo M De Marzo
Journal:  Nat Rev Urol       Date:  2017-10-31       Impact factor: 14.432

2.  Bacterial Prostatitis Enhances 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine (PhIP)-Induced Cancer at Multiple Sites.

Authors:  Karen S Sfanos; Kirstie Canene-Adams; Heidi Hempel; Shu-Han Yu; Brian W Simons; Anthony J Schaeffer; Edward M Schaeffer; William G Nelson; Angelo M De Marzo
Journal:  Cancer Prev Res (Phila)       Date:  2015-05-19

3.  The common parasite Toxoplasma gondii induces prostatic inflammation and microglandular hyperplasia in a mouse model.

Authors:  Darrelle L Colinot; Tamila Garbuz; Maarten C Bosland; Liang Wang; Susan E Rice; William J Sullivan; Gustavo Arrizabalaga; Travis J Jerde
Journal:  Prostate       Date:  2017-05-12       Impact factor: 4.104

4.  Activation of sphingosine kinase by lipopolysaccharide promotes prostate cancer cell invasion and metastasis via SphK1/S1PR4/matriptase.

Authors:  Cheng-Fan Lee; Andrew Dang; Elizabeth Hernandez; Rey-Chen Pong; Benjamin Chen; Rajni Sonavane; Ganesh Raj; Payal Kapur; Hsin-Ying Lin; Shang-Ru Wu; Chun-Jung Ko; U-Ging Lo; Hsin-Yu Lee; Jer-Tsong Hsieh; Ming-Shyue Lee
Journal:  Oncogene       Date:  2019-05-31       Impact factor: 9.867

Review 5.  The role of the prostate in male fertility, health and disease.

Authors:  Paolo Verze; Tommaso Cai; Stefano Lorenzetti
Journal:  Nat Rev Urol       Date:  2016-06-01       Impact factor: 14.432

6.  Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression.

Authors:  Robert M Hughes; Brian W Simons; Hamda Khan; Rebecca Miller; Valentina Kugler; Samantha Torquato; Debebe Theodros; Michael C Haffner; Tamara Lotan; Jessie Huang; Elai Davicioni; Steven S An; Ryan C Riddle; Daniel L J Thorek; Isla P Garraway; Elana J Fertig; John T Isaacs; W Nathaniel Brennen; Ben H Park; Paula J Hurley
Journal:  Cancer Res       Date:  2019-05-23       Impact factor: 12.701

7.  Sex differences in IL-17 contribute to chronicity in male versus female urinary tract infection.

Authors:  Anna Zychlinsky Scharff; Matthieu Rousseau; Livia Lacerda Mariano; Tracy Canton; Camila Rosat Consiglio; Matthew L Albert; Magnus Fontes; Darragh Duffy; Molly A Ingersoll
Journal:  JCI Insight       Date:  2019-05-30

8.  Non-Cell-Autonomous Regulation of Prostate Epithelial Homeostasis by Androgen Receptor.

Authors:  Boyu Zhang; Oh-Joon Kwon; Gervaise Henry; Alicia Malewska; Xing Wei; Li Zhang; William Brinkley; Yiqun Zhang; Patricia D Castro; Mark Titus; Rui Chen; Mohammad Sayeeduddin; Ganesh V Raj; Ryan Mauck; Claus Roehrborn; Chad J Creighton; Douglas W Strand; Michael M Ittmann; Li Xin
Journal:  Mol Cell       Date:  2016-09-01       Impact factor: 17.970

9.  Nucleotide-binding oligomerization domain 1 acts in concert with the cholecystokinin receptor agonist, cerulein, to induce IL-33-dependent chronic pancreatitis.

Authors:  T Watanabe; Y Sadakane; N Yagama; T Sakurai; H Ezoe; M Kudo; T Chiba; W Strober
Journal:  Mucosal Immunol       Date:  2016-01-27       Impact factor: 7.313

10.  A Murine Orthotopic Allograft to Model Prostate Cancer Growth and Metastasis.

Authors:  Robert M Hughes; Brian W Simons; Paula J Hurley
Journal:  Bio Protoc       Date:  2017-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.